CCL2 and metabolic disease: Metabolic disorders associated with chronic diseases and inflammation were demonstrated by a high concentration of pro-inflammatory markers such as TNF-α, MCP-1 and IL-6, and a decrease in anti-inflammatory factors such as adiponectin.